Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Krueger, J. Kunde, R. Marre, N. Suttorp, T. Welte (Aachen, Henningsdorf, Ulm, Berlin, Hannover, Germany). Hyponatremia in community-acquired pneumonia due to increased vasopressin secretion – impact on mortality. Eur Respir J 2009; 34: Suppl. 53, 1787

Member's Comments

No comment yet.

Related content which might interest you: Dysnatremia, vasopressin, atrial natriuretic peptide and mortality in community-acquired pneumonia – Results from the German competence network CAPNETZ Source: Annual Congress 2011 - Severity, comorbidities and outcomes in community-acquired pneumonia Year: 2011 Procalcitonin and neopterin in community-acquired pneumonia – correlation with microbial aetiology, severity and mortality Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Admission hypoglycaemia is associated with adverse outcome in community-acquired pneumonia Source: Eur Respir J 2009; 34: 932-939 Year: 2009 Pro-vasopressin (copeptin) in patients with community-acquired pneumonia – influence of antibiotic pre-treatment; results from the German competence network CAPNETZ Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009 Adrenal function in patients with community-acquired pneumonia Source: Eur Respir J 2008; 31: 1268-1273 Year: 2008 Do admission glucose levels aid in predicting mortality associated with community-acquired pneumonia? Source: Eur Respir J, 50 (4) 1700307; 10.1183/13993003.00307-2017 Year: 2017 Clostridium difficile infection following community-acquired pneumonia Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011 Thrombocytopenia predicts severity and mortality in CAP – Experience of developing country hospital Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012 Factors influencing in-hospital mortality in community-acquired pneumonia (CAP) Source: Eur Respir J 2006; 28: Suppl. 50, 352s Year: 2006 Legionella pneumonia in patients hospitalized with community-acquired pneumonia (CAP) in Norway Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012 Community-acquired pneumonia in the elderly Source: Eur Respir Mon; 2009: 43: 111–132 Year: 2009 Obesity is associated with improved survival in community-acquired pneumonia Source: Eur Respir J 2013; 42: 180-187 Year: 2013 Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia Source: Eur Respir J 2009; 33: 153-159 Year: 2009 COPD is associated with increased mortality in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: 346-351 Year: 2006 The impact of comorbidities on the in-hospital mortality in patients with community-acquired pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 Analysis of the mortality caused by community-acquired pneumonia in the elderly Source: Eur Respir J 2005; 26: Suppl. 49, 544s Year: 2005 Community-acquired pneumonia in outpatients: aetiology and outcomes}, Source: Eur Respir J 2012; 40: 931-938 Year: 2012 Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Community-acquired pneumonia with severe sepsis: Etiology and prognosis Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013 Prohormones of adrenomedullin, atrial natriuretic peptide, vasopressin and endothelin to predict short- and long-term survival in community-acquired pneumonia – Results from the German competence network CAPNETZ Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia Year: 2010